Anda belum login :: 23 Nov 2024 14:43 WIB
Home
|
Logon
Hidden
»
Administration
»
Collection Detail
Detail
Complications in surgery for Crohn's disease after preoperative antitumour necrosis factor therapy
Oleh:
Myrelid, P.
;
Marti-Gallostra, M.
;
Ashraf, S.
;
Sunde, M. L.
;
Tholin, M.
Jenis:
Article from Article - diterbitkan di jurnal ilmiah internasional
Dalam koleksi:
BJS: British Journal of Surgery vol. 101 no. 05 (Apr. 2014)
,
page 539-545.
Ketersediaan
Perpustakaan FK
Nomor Panggil:
B15.K.2014.01
Non-tandon:
1 (dapat dipinjam: 0)
Tandon:
tidak ada
Lihat Detail Induk
Isi artikel
Background The use of biological therapy (biologicals) is established in the treatment of Crohn's disease. This study aimed to determine whether preoperative treatment with biologicals is associated with an increased rate of complications following surgery for Crohn's disease with intestinal anastomosis. Methods All patients receiving biologicals and undergoing abdominal surgery with anastomosis or strictureplasty were identified at six tertiary referral centres. Demographic data, and preoperative, operative and postoperative details were registered. Patients who were treated with biologicals within 2?months before surgery were compared with a control group who were not. Postoperative complications were classified according to anastomotic, infectious or other complications, and graded according to the Clavien–Dindo classification. Results Some 111 patients treated with biologicals within 2?months before surgery were compared with 187 patients in the control group. The groups were well matched. There were no differences between the treatment and control groups in the rate of complications of any type (34·2 versus 28·9 per cent respectively; P?=?0·402), anastomotic complications (7·2 versus 8·0 per cent; P?=?0·976) and non-anastomotic infectious complications (16·2 versus 13·9 per cent; P?=?0·586). In univariable regression analysis, biologicals were not associated with an increased risk of any complication (odds ratio (OR) 1·33, 95 per cent confidence interval 0·81 to 2·20), anastomotic complication (OR 0·89, 0·37 to 2·17) or infectious complication (OR 1·09, 0·62 to 1·91). Conclusion Treatment with biologicals within 2?months of surgery for Crohn's disease with intestinal anastomosis was not associated with an increased risk of complications.
Opini Anda
Klik untuk menuliskan opini Anda tentang koleksi ini!
Kembali
Process time: 0.015625 second(s)